Company
United StatesPublic company, NYSE: GWWW.W. Grainger, Inc. (NYSE: GWW), Springfield, MO – FDA Inspections
Inspection records and compliance data for W.W. Grainger, Inc. in Springfield, MO. 2 FDA inspections on record, last inspected February 21, 2024. Publicly traded as NYSE: GWW.
Company Profile
This profile covers W.W. Grainger, Inc. based in Springfield, MO, United States.
FDA Inspection History
- FDA inspections
- 2
- OAI
- 0
- VAI
- 0
- NAI
- 0
- Unclassified
- 2
- Form 483s
- 0
- Warning letters
- 0
First inspected January 10, 2019. Last inspected February 21, 2024.
FDA inspections (2)
| Date | Result | FDA center(s) | Insp. # |
|---|---|---|---|
| February 21, 2024 | Not classified | Foods & Cosmetics | 1231152 |
| January 10, 2019 | Not classified | Foods & Cosmetics | 1076357 |
FDA documents
No Form 483s, Warning Letters or EIRs on record.
Related Companies (10)
Companies with similar regulatory profiles, compliance history, and operations.
Company Information
Name
W.W. Grainger, Inc.
Stock ticker
GWW
Exchange
NYSE
Share price
$1,456.58
Market cap
$68.2B
Price as of
November 6, 2026
FEI Number
3012147354
Address
808 N Cedarbrook Ave, Springfield, MO 65802-2522, United States
Country
United States
ID: a047ee93-36d6-4b79-8580-492b6ec06913